TABLE V.
Outcome | Episode severity level* | No. | Episodes that were not treated with OCSs (n = 585) |
Episodes that were treated with OCSs (n = 161) |
Pvalue |
---|---|---|---|---|---|
AUC total symptoms score | Less severe episodes | 613 | 4.4 (0.18) | 4.8 (0.24) | .18 |
More severe episodes | 133 | 4.6 (0.36) | 4.9 (0.34) | .46 | |
AUC cough score | Less severe episodes | 613 | 3.0 (0.11) | 3.2 (0.17) | .26 |
More severe episodes | 133 | 3.1 (0.22) | 3.2 (0.22) | .83 | |
AUC wheeze score | Less severe episodes | 613 | 1.5 (0.11) | 1.8 (0.14) | .01 |
More severe episodes | 133 | 1.6 (0.23) | 2.1 (0.20) | .05 | |
AUC trouble breathing score | Less severe episodes | 613 | 1.7 (0.11) | 1.9 (0.13) | .25 |
More severe episodes | 133 | 1.9 (0.22) | 2.0 (0.19) | .76 | |
AUC interference with activity score | Less severe episodes | 613 | 1.6 (0.11) | 1.8 (0.14) | .36 |
More severe episodes | 133 | 1.5 (0.21) | 1.6 (0.20) | .53 |
Data are stratified based on the episode’s severity: less severe episodes (n = 613) and more severe episodes (n = 133). The square root transformation was applied to all AUCs to improve the approximate normality of the AUC measurements. Data are represented as means (SEs) of the square root of AUCs. All comparisons were adjusted for maximum propensity score (natural log) along with correlation among repeated measurements.
Episode severity was defined based on a propensity score of greater than or less than 0.2.